Sneha Somasekar
University of California, San Francisco
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Sneha Somasekar.
The New England Journal of Medicine | 2014
Michael R. Wilson; Samia N. Naccache; Erik Samayoa; Mark Biagtan; Hiba Bashir; Guixia Yu; Shahriar M. Salamat; Sneha Somasekar; Scot Federman; Steve Miller; Robert A. Sokolic; Elizabeth Garabedian; Fabio Candotti; Rebecca H. Buckley; Kurt D. Reed; Teresa L. Meyer; Christine M. Seroogy; Renee Galloway; Sheryl L. Henderson; James E. Gern; Joseph L. DeRisi; Charles Y. Chiu
A 14-year-old boy with severe combined immunodeficiency presented three times to a medical facility over a period of 4 months with fever and headache that progressed to hydrocephalus and status epilepticus necessitating a medically induced coma. Diagnostic workup including brain biopsy was unrevealing. Unbiased next-generation sequencing of the cerebrospinal fluid identified 475 of 3,063,784 sequence reads (0.016%) corresponding to leptospira infection. Clinical assays for leptospirosis were negative. Targeted antimicrobial agents were administered, and the patient was discharged home 32 days later with a status close to his premorbid condition. Polymerase-chain-reaction (PCR) and serologic testing at the Centers for Disease Control and Prevention (CDC) subsequently confirmed evidence of Leptospira santarosai infection.
Lancet Infectious Diseases | 2015
Alexander L. Greninger; Samia N. Naccache; Kevin Messacar; Anna Clayton; Guixia Yu; Sneha Somasekar; Scot Federman; Doug Stryke; Christopher Anderson; Shigeo Yagi; Sharon Messenger; Debra A. Wadford; Dongxiang Xia; James Watt; Keith Van Haren; Samuel R. Dominguez; Carol A. Glaser; Grace M. Aldrovandi; Charles Y. Chiu
BACKGROUND Enterovirus D68 was implicated in a widespread outbreak of severe respiratory illness across the USA in 2014 and has also been reported sporadically in patients with acute flaccid myelitis. We aimed to investigate the association between enterovirus D68 infection and acute flaccid myelitis during the 2014 enterovirus D68 respiratory outbreak in the USA. METHODS Patients with acute flaccid myelitis who presented to two hospitals in Colorado and California, USA, between Nov 24, 2013, and Oct 11, 2014, were included in the study. Additional cases identified from Jan 1, 2012, to Oct 4, 2014, via statewide surveillance were provided by the California Department of Public Health. We investigated the cause of these cases by metagenomic next-generation sequencing, viral genome recovery, and enterovirus D68 phylogenetic analysis. We compared patients with acute flaccid myelitis who were positive for enterovirus D68 with those with acute flaccid myelitis but negative for enterovirus D68 using the two-tailed Fishers exact test, two-sample unpaired t test, and Mann-Whitney U test. FINDINGS 48 patients were included: 25 with acute flaccid myelitis, two with enterovirus-associated encephalitis, five with enterovirus-D68-associated upper respiratory illness, and 16 with aseptic meningitis or encephalitis who tested positive for enterovirus. Enterovirus D68 was detected in respiratory secretions from seven (64%) of 11 patients comprising two temporally and geographically linked acute flaccid myelitis clusters at the height of the 2014 outbreak, and from 12 (48%) of 25 patients with acute flaccid myelitis overall. Phylogenetic analysis revealed that all enterovirus D68 sequences associated with acute flaccid myelitis grouped into a clade B1 strain that emerged in 2010. Of six coding polymorphisms in the clade B1 enterovirus D68 polyprotein, five were present in neuropathogenic poliovirus or enterovirus D70, or both. One child with acute flaccid myelitis and a sibling with only upper respiratory illness were both infected by identical enterovirus D68 strains. Enterovirus D68 viraemia was identified in a child experiencing acute neurological progression of his paralytic illness. Deep metagenomic sequencing of cerebrospinal fluid from 14 patients with acute flaccid myelitis did not reveal evidence of an alternative infectious cause to enterovirus D68. INTERPRETATION These findings strengthen the putative association between enterovirus D68 and acute flaccid myelitis and the contention that acute flaccid myelitis is a rare yet severe clinical manifestation of enterovirus D68 infection in susceptible hosts. FUNDING National Institutes of Health, University of California, Abbott Laboratories, and the Centers for Disease Control and Prevention.
Nature | 2017
Nuno Rodrigues Faria; Josh Quick; Julien Thézé; J. G. de Jesus; Marta Giovanetti; Moritz U. G. Kraemer; Sarah C. Hill; Allison Black; A. C. da Costa; Luciano Franco; Sandro Patroca da Silva; Chieh-Hsi Wu; Jayna Raghwani; Simon Cauchemez; L. du Plessis; M. P. Verotti; W. K. de Oliveira; E. H. Carmo; Giovanini Evelim Coelho; A. C. F. S. Santelli; L. C. Vinhal; C. M. Henriques; Jared T. Simpson; Matthew Loose; Kristian G. Andersen; Nathan D. Grubaugh; Sneha Somasekar; Charles Y. Chiu; José Esteban Muñoz-Medina; César González-Bonilla
Transmission of Zika virus (ZIKV) in the Americas was first confirmed in May 2015 in northeast Brazil. Brazil has had the highest number of reported ZIKV cases worldwide (more than 200,000 by 24 December 2016) and the most cases associated with microcephaly and other birth defects (2,366 confirmed by 31 December 2016). Since the initial detection of ZIKV in Brazil, more than 45 countries in the Americas have reported local ZIKV transmission, with 24 of these reporting severe ZIKV-associated disease. However, the origin and epidemic history of ZIKV in Brazil and the Americas remain poorly understood, despite the value of this information for interpreting observed trends in reported microcephaly. Here we address this issue by generating 54 complete or partial ZIKV genomes, mostly from Brazil, and reporting data generated by a mobile genomics laboratory that travelled across northeast Brazil in 2016. One sequence represents the earliest confirmed ZIKV infection in Brazil. Analyses of viral genomes with ecological and epidemiological data yield an estimate that ZIKV was present in northeast Brazil by February 2014 and is likely to have disseminated from there, nationally and internationally, before the first detection of ZIKV in the Americas. Estimated dates for the international spread of ZIKV from Brazil indicate the duration of pre-detection cryptic transmission in recipient regions. The role of northeast Brazil in the establishment of ZIKV in the Americas is further supported by geographic analysis of ZIKV transmission potential and by estimates of the basic reproduction number of the virus.
Journal of Clinical Microbiology | 2016
Silvia Ines Sardi; Sneha Somasekar; Samia N. Naccache; Antonio Carlos Bandeira; Laura B. Tauro; Gubio Soares Campos; Charles Y. Chiu
ABSTRACT Metagenomic next-generation sequencing (mNGS) of samples from 15 patients with documented Zika virus (ZIKV) infection in Bahia, Brazil, from April 2015 to January 2016 identified coinfections with chikungunya virus (CHIKV) in 2 of 15 ZIKV-positive cases by PCR (13.3%). While generally nonspecific, the clinical presentation corresponding to these two CHIKV/ZIKV coinfections reflected infection by the virus present at a higher titer. Aside from CHIKV and ZIKV, coinfections of other viral pathogens were not detected. The mNGS approach is promising for differential diagnosis of acute febrile illness and identification of coinfections, although targeted arbovirus screening may be sufficient in the current ZIKV outbreak setting.
Emerging Infectious Diseases | 2016
Samia N. Naccache; Julien Thézé; Silvia Ines Sardi; Sneha Somasekar; Alexander L. Greninger; Antonio Carlos Bandeira; Gubio Soares Campos; Laura B. Tauro; Nuno Rodrigues Faria; Oliver G. Pybus; Charles Y. Chiu
Sequencing of isolates from patients in Bahia, Brazil, where most Zika virus cases in Brazil have been reported, resulted in 11 whole and partial Zika virus genomes. Phylogenetic analyses revealed a well-supported Bahia-specific Zika virus lineage, which indicates sustained Zika virus circulation in Salvador, Bahia’s capital city, since mid-2014.
Scientific Reports | 2017
Sarah Castro-Wallace; Charles Y. Chiu; Kristen K. John; Sarah E. Stahl; Kathleen H. Rubins; Alexa B. R. McIntyre; Jason P. Dworkin; Mark L. Lupisella; David J. Smith; Douglas J. Botkin; Timothy Stephenson; Sissel Juul; Daniel J. Turner; Fernando Izquierdo; Scot Federman; Doug Stryke; Sneha Somasekar; Noah Alexander; Guixia Yu; Christopher E. Mason; Aaron S. Burton
We evaluated the performance of the MinION DNA sequencer in-flight on the International Space Station (ISS), and benchmarked its performance off-Earth against the MinION, Illumina MiSeq, and PacBio RS II sequencing platforms in terrestrial laboratories. Samples contained equimolar mixtures of genomic DNA from lambda bacteriophage, Escherichia coli (strain K12, MG1655) and Mus musculus (female BALB/c mouse). Nine sequencing runs were performed aboard the ISS over a 6-month period, yielding a total of 276,882 reads with no apparent decrease in performance over time. From sequence data collected aboard the ISS, we constructed directed assemblies of the ~4.6 Mb E. coli genome, ~48.5 kb lambda genome, and a representative M. musculus sequence (the ~16.3 kb mitochondrial genome), at 100%, 100%, and 96.7% consensus pairwise identity, respectively; de novo assembly of the E. coli genome from raw reads yielded a single contig comprising 99.9% of the genome at 98.6% consensus pairwise identity. Simulated real-time analyses of in-flight sequence data using an automated bioinformatic pipeline and laptop-based genomic assembly demonstrated the feasibility of sequencing analysis and microbial identification aboard the ISS. These findings illustrate the potential for sequencing applications including disease diagnosis, environmental monitoring, and elucidating the molecular basis for how organisms respond to spaceflight.
Emerging Infectious Diseases | 2017
Charles Y. Chiu; Lark L. Coffey; Jamie Murkey; Kelly Symmes; Hannah A. Sample; Michael R. Wilson; Samia N. Naccache; Shaun Arevalo; Sneha Somasekar; Scot Federman; Doug Stryke; Paul Vespa; Gary J. Schiller; Sharon Messenger; Romney M. Humphries; Steve Miller; Jeffrey D. Klausner
We used unbiased metagenomic next-generation sequencing to diagnose a fatal case of meningoencephalitis caused by St. Louis encephalitis virus in a patient from California in September 2016. This case is associated with the recent 2015–2016 reemergence of this virus in the southwestern United States.
Clinical Infectious Diseases | 2017
Sneha Somasekar; Deanna Lee; Jody Rule; Samia N. Naccache; Mars Stone; Michael P. Busch; Corron Sanders; William M. Lee; Charles Y. Chiu
Viral metagenomic surveillance of 187 patients with indeterminate acute liver failure (ALF) from 1998 to 2010 suggests that these patients should be screened for the presence of uncommon viruses and coinfections, although novel viruses associated with ALF were not identified.
Cell Host & Microbe | 2018
Julien Thézé; Tony Li; Louis du Plessis; Jerome Bouquet; Moritz U. G. Kraemer; Sneha Somasekar; Guixia Yu; Mariateresa de Cesare; Angel Balmaseda; Guillermina Kuan; Eva Harris; Chieh-Hsi Wu; M. Azim Ansari; Rory Bowden; Nuno Rodrigues Faria; Shigeo Yagi; Sharon Messenger; Trevor Brooks; Mars Stone; Evan M. Bloch; Michael P. Busch; José Esteban Muñoz-Medina; César González-Bonilla; Steven M. Wolinsky; Susana López; Carlos F. Arias; David Bonsall; Charles Y. Chiu; Oliver G. Pybus
Summary The Zika virus (ZIKV) epidemic in the Americas established ZIKV as a major public health threat and uncovered its association with severe diseases, including microcephaly. However, genetic epidemiology in some at-risk regions, particularly Central America and Mexico, remains limited. We report 61 ZIKV genomes from this region, generated using metagenomic sequencing with ZIKV-specific enrichment, and combine phylogenetic, epidemiological, and environmental data to reconstruct ZIKV transmission. These analyses revealed multiple independent ZIKV introductions to Central America and Mexico. One introduction, likely from Brazil via Honduras, led to most infections and the undetected spread of ZIKV through the region from late 2014. Multiple lines of evidence indicate biannual peaks of ZIKV transmission in the region, likely driven by varying local environmental conditions for mosquito vectors and herd immunity. The spatial and temporal heterogeneity of ZIKV transmission in Central America and Mexico challenges arbovirus surveillance and disease control measures.
PLOS ONE | 2015
Ozlen Saglam; Erik Samayoa; Sneha Somasekar; Samia N. Naccache; Akiko Iwasaki; Charles Y. Chiu
Vulvar Intraepithelial Neoplasia (VIN) is the precursor lesion of Vulvar Squamous Cell Carcinoma (VSCC), and the differentiated type (dVIN) is more frequently observed in relation to VSCC. In contrast to usual-type VIN (uVIN), which is related to infection by human papillomavirus (HPV), a germline mutation in the p53 gene is thought to be associated with ~90% of dVIN cases. To date, no infectious agent has been identified in association with dVIN, and studies investigating this possibility have been hindered by the difficulty in accurately diagnosing dVIN from small biopsies. Here, we used immunostaining for p16ink4a, a biomarker for HPV infection, to study 14 uVIN high-grade VIN and 14 dVIN cases, and to select 10 dVIN cases to broadly screen for all known viruses using a pan-viral microarray platform (ViroChip). All of the uVIN tissue samples, including 8 warty and 6 basaloid cases, showed positivity with the p16ink4a immunostain. The staining pattern was full-thickness for all except two cases in which positive staining was localized in the lower 1/3 of the epidermis. In contrast, immunostaining for p16ink4a was negative in all dVIN cases. ViroChip analysis of 10 pure dVIN samples confirmed the absence of human papillomavirus subtypes or any other virus with the exception of a single sample that showed a weak microarray signature to a porcine herpesvirus. Follow-up PCR testing of the sample was negative for herpesvirus, and in-depth metagenomic next-generation sequencing revealed only sequences corresponding to non-pathogenic viral flora and bacterial contamination. In this study, we demonstrated lack of a virus association in 10 dVIN cases. Alternative pathways for carcinogenesis such as the p53 mutation should be considered for investigation of potential treatment options in dVIN.